​As the epidemic continues to spread worldwide, the number of COVID-19 confirmed cases in India has been the second of the world, only behind the United States. The maximum daily confirmed cases in India reaches as many as 400000. Tens of thousands of Indians died in this epidemic disaster due to the serious shortage of vaccines, medical equipment and epidemic prevention materials. Among them, the

Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart